Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets

v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2023
Dec. 31, 2022
 [1]
Current Assets:    
Cash and cash equivalents $ 21,173 $ 36,456
Restricted cash 5,263 13,069
Accounts receivable (net of allowance for credit losses of $66 and $105, respectively) 66,537 68,655
Inventories 67,147 66,628
Derivative instruments 6,267 4,973
Other current assets 5,217 9,340
Total current assets 171,604 199,121
Property and equipment, net 244,172 239,069
Other Assets:    
Right of use operating lease assets, net 23,046 18,937
Intangible assets, net 8,940 9,087
Goodwill 5,970 5,970
Other assets 6,172 6,137
Total other assets 44,128 40,131
Total Assets 459,904 478,321
Current Liabilities:    
Accounts payable 24,406 28,115
Accrued liabilities 17,334 26,556
Current portion – operating leases 3,856 3,849
Derivative instruments 2,100 6,732
Other current liabilities 6,150 12,765
Total current liabilities 53,846 78,017
Long-term debt 83,739 68,356
Operating leases, net of current portion 19,678 15,062
Other liabilities 8,966 8,797
Total Liabilities 166,229 170,232
Commitments and Contingencies (Note 6)
Stockholders’ Equity:    
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 1,684 shares authorized; no shares issued and outstanding as of March 31, 2023 and December 31, 2022; Series B: 1,581 shares authorized; 927 shares issued and outstanding as of March 31, 2023 and December 31, 2022; liquidation preference of $18,075 as of March 31, 2023 1 1
Common stock, value 76 75
Additional paid-in capital 1,039,897 1,040,834
Accumulated other comprehensive income 1,822 1,822
Accumulated deficit (748,121) (734,643)
Total Stockholders’ Equity 293,675 308,089
Total Liabilities and Stockholders’ Equity 459,904 478,321
Non-voting common stock    
Stockholders’ Equity:    
Common stock, value
[1] Amounts derived from the audited financial statements for the year ended December 31, 2022.